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The distribution of hepatitis B virus genotypes in Saudi Arabia is largely unknown. To the
best of our knowledge there are no data available about HBV genotypes in southwestern
region of the country. This study aimed to determine the epidemiologic distribution of hep-
atitis  B virus genotypes in chronic hepatitis B patients in southwestern region, and to verify
possible correlations between these genotypes and the clinical symptoms. A total of 160
patients with chronic hepatitis B infection were enrolled in this study. Sera were tested
for  liver function tests, hepatitis B virus markers and DNA load by standard procedures.
HBV genotyping was performed by 2-tube nested PCR for determination of six genotypes
(A–F).  Genotype D was the most common, found in 135 (84.4%) patients, followed by A (18;
11.3%) and E (7; 4.3%). The rate of HBeAg positivity in genotype D patients was signiﬁcantly
lower compared with that in genotype A and E patients (p = 0.01). There was no signiﬁcant
association between HBV genotypes and age, gender, liver function tests, or HBV DNA load.
Genotypes D and E were predominant in chronic hepatitis B patients in southwestern Saudi
Arabia. Awareness of hepatitis B virus serologic and genotypic patterns might help in theformulation of management plans, predicting clinical outcomes and updating prevention
strategies.
©  2015 Elsevier Editora Ltda. All rights reserved.epatitis B virus (HBV) infection is a potentially life-
hreatening liver disease and represents a major global health
roblem. About two billion people have been infected with
BV worldwide, and 400 million among them are suffer-
1,2ng from chronic HBV (CHB) infection. In Saudi Arabia,
he prevalence of HBV infection has declined considerably
ince the introduction of the HBV vaccine in the national
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have shown that HBV infections continue to be a major burden
on the Saudi healthcare system. According to Algarni et al.,
23,236 cases of HBV infection have been reported to the Saudiicine, Najran University, P.O. Box 1988, Najran, Saudi Arabia.
du.sa (A.M. Asaad), drmzayed2000@yahoo.com (M.S.Z. Al-Ayed),
eshi).
Ministry of Health during the 5-year period from 2009 to 2013
and the incidence rates were 19.3 and 14.7 per 100,000 popu-
lations in 2009 and 2013, respectively.4
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Table 1 – Characteristics of 160 patients with chronic
HBV infection.
Characteristics Values
Mean age (years) 41.6 ± 4.9
Gender (male/female) 124/36
Total bilirubin (mol/L; normal: 3–17) 16.5 ± 1.3
Albumin (g/L; normal: 34–50) 39.4 ± 2.5
Serum AST (U/L; normal: 15–37) 86.2 ± 32.1
Serum ALT (U/L; normal: 25–65) 168.7 ± 58.9
HBeAg (positive/negative, n) 74/86
HBV DNA load (log10 copies/ml) 15.5 ± 3.4
Genotype D (n, %) 135,  84.4%526  b r a z j i n f e c t d 
According to the molecular evolutionary analysis of
genomic DNA sequence, HBV strains isolated in various
countries are classiﬁed into ten genotypes, designated A–J,
and arbitrarily deﬁned by an inter-group sequence divergence
of more  than 8% based on complete genomes.5,6 Genotype
distribution shows variations between countries, and even
between geographical regions within countries. Genotype A
is widespread in sub-Saharan Africa, Northern Europe, and
Western Africa; genotypes B and C are common in Asia; geno-
type C is primarily observed in Southeast Asia; genotype D
is dominant in Africa, Europe, Mediterranean countries, and
India; genotype E is found in central and western Africa; geno-
type F is dominant in Latin America and Alaska; genotype G
is reported in France, Germany, and the United States; and
genotype H is commonly encountered in Central and South
America. Genotype I has recently been reported in Vietnam
and Laos. The newest HBV genotype, genotype J, has been
identiﬁed in Japan.6–11
Genotyping of HBV is essential for characterization of
patient groups and for epidemiological studies. The clinical
signiﬁcance of different HBV genotypes has become increas-
ingly recognized in patients with acute and CHB infection.8–10
Moreover, several studies have shown a strong relationship
between HBV genotypes and mutations in the pre-core and
core promoter regions that abolish or diminish the production
of hepatitis B e antigen (HBeAg). The course of HBV infection
depends on several factors such as host genetic factors, age
and genetic variability of the virus. In addition to the epidemi-
ological importance, HBV genotypes may inﬂuence the disease
pattern and response to treatment.6,12
The distribution of HBV genotypes in the Kingdom of
Saudi Arabia is largely unknown, and only a few studies
have reported the predominance of HBV genotype D in some
locations.13,14 To the best of our knowledge there are no data
available about HBV genotypes in the southwestern region.
Hence, the aims of our study were to determine the epidemi-
ologic distribution of HBV genotypes in Saudi patients with
CHB in Najran, a city in southwestern Saudi Arabia, and to
verify possible correlations between these genotypes and the
clinical symptoms.
This cross-sectional study was conducted at King Khalid
Hospital, a 350-bed tertiary care hospital in Najran during a
6-month period from February to October 2014. A total of 160
patients with CHB infection, followed as outpatients at the
department of internal medicine were enrolled in this study.
Sixty-ﬁve (40.6%) patients received treatment with lamivu-
dine monotherapy. Five (3.1%) patients received lamivudine
followed by add-on adefovir, while none of the remaining 90
(56.3%) patients had ever received antiviral treatment. The
inclusion criteria were all patients who were serum HBsAg
positive for at least six months with elevated ALT levels (>1.5
times the upper limit of normal; 65 U/L). All of the patients
were diagnosed after they had been previously followed for
at least 12 months. The exclusion criteria were patients with
acute HAV, HBV, HCV, or HDV, patients with evidence for
hepatocellular carcinoma (HCC), or concomitant of HCV, HDV,
HIV infection, metastatic or autoimmune liver disease and
drug induced acute hepatitis. The socio-demographic data and
laboratory tests results were recorded using a standardized
questionnaire, including the age, gender, underlying medicalGenotype A (n, %) 18,  11.3%
Genotype E (n, %) 7, 4.3%
conditions, signs and symptoms at presentation, ﬁndings on
physical examination, laboratory ﬁndings, and deﬁnitive clin-
ical diagnosis.
The levels of serum total bilirubin, albumin, alanine amino-
transferase (ALT) and aspartate transaminase (AST) were
determined with routine automated techniques. The HBV
markers (HBsAg, HBsAb, HBeAg, HBeAb, HBcAb, and anti-HBc
Ab IgM) were measured using the enzyme-linked immunosor-
bent assay (ELISA) kits (Roche Laboratories, Branchburg, NJ,
USA). Serum HBV DNA load in patients with CHB was mea-
sured by a sensitive PCR based assay (COBAS Amplicor, Roche
Diagnostics, Branchburg, NJ, USA) with a lower detection limit
of approximately 200 copies/mL. HBV genotyping was per-
formed by 2-tube nested PCR, using type speciﬁc primers for
determination of six genotypes A through F of HBV according
to a method previous described by Farazmandfar et al.15
Data were analyzed using the Statistical Package for the
Social Sciences (SPSS), Version 15.0 (SPSS Inc., Chicago, IL,
USA). Statistical signiﬁcance was deﬁned as a p-value less than
0.05.
The demographic, serological and virological characteris-
tics of the patients are summarized in Table 1. The patients
were between 32 and 52 years of age with a median age of 41
years. Of these patients, 124 (77.5%) were male and 36 (22.5%)
were female. Hepatitis B genotyping revealed that 135 patients
(84.4%) had genotype D, 18 patients (11.3%) had genotype A,
and 7 patients (4.3%) had genotype E. No other HBV geno-
type or mixed infections were detected in patients enrolled
for this study. The demographic, serological and virological
characteristics were compared among patients with the dif-
ferent genotypes (Table 2). Univariate analysis indicated that
the rate of HBeAg positivity in genotype D patients was sig-
niﬁcantly lower compared with that in genotype A and E
patients (p = 0.01). However, there was no signiﬁcant associ-
ation between HBV genotypes and age, gender, liver function
tests, or HBV DNA load.
CHB is an important medical problem in Saudi Arabia,
which is currently classiﬁed by the WHO  as an area of high
endemicity (≥8% of population are HBsAg positive).1 Detection
of HBV genotype is very important to clarify the pathogenesis,
routes of infection and virulence of the virus. However, there
is a paucity of information on HBV genotype patterns in Saudi
Arabia. In this study, we found that the majority (84.4%) of
patients were infected with HBV genotype D, followed by geno-
types A (11.3%) and E (4.3%). These results are consistent with
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Table 2 – Characteristics of 160 patients with chronic HBV infection, classiﬁed by HBV genotype.
Characteristics HBV  genotype p-Value
D (n = 135) A (n = 18) E (n = 7)
Mean age (years) 42.9 + 4.9 39.7 + 4.1 41.4 + 5.3 0.12
Gender (male/female) 102/33 16/2 6/1 0.28
Total bilirubin (mol/L; normal: 3–17) 16.5 ± 1.4 16.4 ± 1.3 16.2 ± 1.2 0.85
Albumin (g/L; normal: 34–50) 39 ± 2.1 39.5 ± 2.7 40.4 ± 2.7 0.19
Serum AST (U/L; normal: 15–37) 95.9 + 29.1 73.4 + 31.6 81.3 + 32.1 0.06
Serum ALT (U/L; normal: 25–65) 167.1 + 59.2 161.2 + 56.1 193.3 + 55 0.48
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rHBeAg (positive/negative, n) 55/80 
HBV DNA load (log10 copies/ml) 1.2 × 106
revious ﬁndings from Saudi Arabia. In a previous Saudi study,
5% of 54 CHB patients had genotype D, while 5.7% and 1.4%
ad genotypes A and E, respectively.14 In another study, Abdo
t al. showed that 81%, 5.7% and 1.4% of 70 hepatitis B patients
ad genotypes D, E, and A, respectively.13 Reports from the
editerranean area, Middle East and central and south Asia
howed that 70–80% or more  of the HBV infections are caused
y genotype D.7,8,16–19
The clinical signiﬁcance of different HBV genotypes has
ecome increasingly recognized in patients with acute and
hronic infection. However, the clinical impact of HBV geno-
ype D has been studied less extensively. In this study, similar
o previous reports, age, gender, serum total bilirubin, liver
nzymes, and HBV DNA levels were not signiﬁcantly different
etween patients infected with genotype D and those infected
ith genotypes A or E.9,10 Contrary to these ﬁndings, Yous-
if et al.18 and Nabuco et al.11 found a signiﬁcant association
etween ALT levels and HBV genotypes with lower ALT lev-
ls observed in genotype D patients and higher DNA levels in
enotype E patients. The clinical outcome of HBV infection
nd the severity of liver disease with genotype D and E are
till controversial. It is well known that patients with CHB may
ave ﬂuctuating serum ALT and HBV-DNA levels. Further anal-
ses in large-scale longitudinal studies are required to better
elineate this relationship.
In chronic infection, levels of viremia are generally low.
ong-term prognosis is poorer among HBeAg negative individ-
als compared to their counterparts who are HBeAg positive.5
n this study, a signiﬁcantly lower rate of HBeAg positivity in
atients with genotype D was reported compared to geno-
ype A and E patients. In agreement, Yousif et al.18 showed
 signiﬁcantly higher frequency of HBeAg positivity in geno-
ype E-infected patients compared to genotype D-infected
atients (29.2% versus 8.3%, p < 0.05). HBeAg negative CHB is
ostly associated with mutations in the pre-core and basal
ore promoter regions that result in prevention or reduction
f HBeAg synthesis without affecting the replicative ability of
he virus.12,17,19 Zaky et al.17 found that 94% of 83 Egyptian
atients infected with HBV genotype D were HBeAg negative,
resumably indicating pre-core or core promoter mutation.
itnik et al.12 examined hepatitis genotypes in 103 Brazilian
atients. Pre-core mutants were found in 32 patients, with a
igher frequency in those infected with genotype D (22 cases).
HBeAg negative CHB is characterized by frequent exacerba-
ion of hepatitis, which probably increases the risk of cirrhosis,
epatic failure, and HCC.5 Baig et al.20 found that 8 of 9 HCC
atients had HBV genotype D and 4 of 5 cirrhotic patients had13/5 3/4 0.01
1.8 × 105 2.3 × 105 0.25
HBV genotype A. Our study did not include patients with cir-
rhosis or HCC. However, in Saudi Arabia, HCC is the second
most common cancer,3 and in a country where HBV is endemic
this could imply a correlation between the most prevalent
genotype D and HCC.
This study had some limitations. Firstly, the relatively small
sample size may have limited our ability to detect differ-
ences even though it included the highest number of patients
genotyped in Saudi Arabia. Secondly, the study included only
CHB group of patients. Therefore, large-scale studies includ-
ing different HBV clinical groups are required to obtain further
information on the role of genotype D and E and their impact
on the progression of liver diseases.
In conclusion, our ﬁndings further illustrate HBV genotype
patterns in Saudi Arabia. Genotypes D and E were predomi-
nant in CHB patients, and D is the most prevalent genotype
in Najran, southwestern Saudi Arabia. The majority of the
patients were HBeAg negative suggesting pre-core or core pro-
moter mutations. Awareness of HBV serologic and genotypic
patterns might help in the formulation of management plans,
predicting clinical outcomes and updating prevention strate-
gies.
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